Delivery Order SPE2DR25D2101-SPE2DR26F46CL
- Not listed
- The Defense Logistics Agency awarded a $1,882.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 20, 2025, with completion scheduled for November 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,145.00 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on November 12, 2025, with completion scheduled for November 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,105.42 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,524.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30 units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at approximately $1 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,408.53 delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for Refresh Plus 0.5% eye drops (30-count unit). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 30, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,044.04 to AmerisourceBergen Drug Corp for the supply of Refresh Plus 0.5% eye drops in 30-unit quantities. This is a firm fixed price, non-competitive delivery order that was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (70 count unit dose) on October 16, 2025, with a ceiling value of $1,214.81 and an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical supply transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46CLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,044.05 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50 units) on December 2, 2025, with completion scheduled for December 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract serves multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/1/25 |